Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Clinical Study to Evaluate the Efficacy and Safety of XKH001 Injection in Trial Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease

NCT07519499 is registered in ClinicalTrials.gov with Zhejiang Kanova Biopharmaceutical Co., LTD as lead sponsor.

NCT NCT07519499
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07519499 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Clinical Study to Evaluate the Efficacy and Safety of XKH001 Injection in Trial Participants With Moderate to Severe Chronic Obstructive Pulmonary Disease
Lead sponsor
Zhejiang Kanova Biopharmaceutical Co., LTD
Phase
Phase 2
Overall status
Not yet recruiting
Start date
April 1, 2026
Completion date
February 1, 2028
Enrollment
75 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

copd